Curanex Pharmaceuticals Inc (CURX) stock
CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.70+0.07 (+1.40%)
Close on Nov 17, 2026Market cap $7.37MP/E –Yield –
Curanex Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Curanex Pharmaceuticals's enterprise value was $157.61M on Nov 11, 2026, against $270.41M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $157.61M | -13.2% |
| 2025 | Dec 31, 2025 | $181.59M | – |
See a number that looks wrong?